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Pentameric ligand-gated ion channels (pLGICs) mediate fast synaptic communication by converting chem-
ical signals into an electrical response. Recently solved agonist-bound and agonist-free structures greatly
extend our understanding of these complexmolecular machines. A key challenge to a full description of func-
tion, however, is the ability to unequivocally relate determined structures to the canonical resting, open, and
desensitized states. Here, we review current understanding of pLGIC structure, with a focus on the confor-
mational changes underlying channel gating. We compare available structural information and review the
evidence supporting the assignment of each structure to a particular conformational state. We discuss mul-
tiple factors thatmay complicate the interpretation of crystal structures, highlighting the potential influence of
lipids and detergents. We contend that further advances in the structural biology of pLGICs will require
deeper insight into the nature of pLGIC-lipid interactions.Cys-loop receptors, including nicotinic acetylcholine (nAChR),
serotonin (5-HT3), glycine, and GABAA/GABAC receptors,
mediate fast chemical to electrical transduction at synapses
throughout the nervous system. Insight into Cys-loop receptor
structure has expanded rapidly in recent years with structures
of water-soluble homologs of the acetylcholine receptor
agonist-binding domain (ABD) (Brejc et al., 2001; Celie et al.,
2005; Dellisanti et al., 2007; Hansen et al., 2005; Li et al.,
2011), the Torpedo nAChR (Unwin, 2005), the prokaryotic pen-
tameric ligand-gated ion channels (pLGICs), Erwinia ligand-
gated ion channel (ELIC) (Hilf and Dutzler, 2008) and Gloebacter
ligand-gated ion channel (GLIC) (Bocquet et al., 2009; Hilf and
Dutzler, 2009), and the Caenorhabditis elegans glutamate-acti-
vated chloride channel (GluCl) (Hibbs and Gouaux, 2011). These
studies firmly establish the structural architecture of the pLGIC
superfamily, in which all members adopt a similar quaternary
structure formed from five subunits (Figure 1).
The basic mechanism that emerges from accumulated struc-
tural, biochemical, and physiological studies is that agonist
binding triggers a structural transition from a channel-closed to
a channel-open conformation, followed by a relatively slow
transition to an agonist-unresponsive desensitized state (see
Figure 6A). Despite increasing structural data obtained in both
the presence and absence of bound agonist, however, our un-
derstanding of channel activation remains clouded by our
inability to unequivocally relate pLGIC structures to these canon-
ical conformations. With this in mind, we introduce the pLGIC
superfamily, review current pLGIC structures, and focus on the
insight these structures provide into the conformational changes
underlying agonist-induced channel gating. We then review evi-
dence supporting the interpretation of each structure in terms of
a specific conformation and discuss plausible causes for dis-
crepancies. We also explore the possible consequences of
detergent-solubilization on pLGIC structure. We conclude that
a better understanding of the effects of lipids/detergents onStructpLGIC structure will be necessary to advance the structural
biology of these important receptors.
From the nAChR to Cys-Loop Receptors and the pLGIC
Superfamily
The identification of an abundant source of a ‘‘nicotinic receptive
substance’’ in the electroplax tissues of both electric eels, Elec-
trophorus, and electric fish, Torpedo (Changeux et al., 1970;
Miledi et al., 1971), originally led to the extensive biochemical
characterization of the nAChR. The nAChR is an acetylcholine-
gated, cation-selective ion channel. It is a heteropentamer,
with a subunit stoichiometry of a2bgd (Weill et al., 1974). Each
subunit contains a large N-terminal ABD, a transmembrane
domain (TMD) consisting of four membrane-spanning a helices
(M1–M4), and a cytoplasmic domain, consisting of an amphi-
pathic helix, MA, located between M3 and M4 (Finer-Moore
and Stroud, 1984). The M2 a helix from each subunit lines the
ion channel pore (Akabas et al., 1994; Akabas et al., 1992; Imoto
et al., 1986), whereas M4 faces the lipid bilayer (Blanton and
Cohen, 1992, 1994). Key residues in the agonist binding site,
including conserved aromatic residues and a vicinal disulfide,
were located in loops ‘‘A’’ to ‘‘F’’ at the interfaces between the
a/g and a/d subunits (Figure 2A).
Further work led to the discovery that the Torpedo nAChR is
part of a family of nicotinic receptors that includes both muscle
and neuronal nAChRs (Changeux, 2012; Taly and Changeux,
2008). In humans, this nicotinic family is part of an even broader
superfamily comprised of both excitatory (acetylcholine and
5-HT3) and inhibitory (glycine and GABAA/GABAC) channels, in
which all members exhibit a similar pentameric architecture
(Schofield et al., 1987; Sine and Engel, 2006). Collectively, this
superfamily is referred to as the ‘‘Cys-loop receptors,’’ because
each subunit contains a conserved 13 residue loop (the b6–b7,
see below) in the ABD that is bracketed by two cysteine residues.
The diversity of Cys-loop receptor subunits leads to a wealth ofure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1271
Figure 1. The Conserved Structural Architecture of pLGICs
(A) Structure of the nicotinic acetylcholine receptor (nAChR) from Torpedo (Protein Data Bank [PDB] ID code 2BG9). A side view of the nAChR pentamer looking
from the membrane plane (left) shows the extracellular agonist-binding (ABD, red), transmembrane pore (TMD, blue) and cytoplasmic (CD, green) domains. Side
chains of residues forming part of the agonist-binding site (aW149) and the channel gate (aL251 and aV255, as well as analogous b-, g- and d-subunit residues)
are shown as tan and yellow spheres, respectively. Views from the synaptic cleft are shown on the right for the ABD (top) and TMD (bottom) with color coding to
highlight the different subunits (a, red; b, blue; g, purple; d, green).
(B) Structures of the prokaryotic pLGICs, ELIC (left; PDB ID code 2VLO) and GLIC (center; PDB ID code 3EAM), and the C. elegans GluCl (PDB ID code 3RIF),
colored as in (A) to highlight the ABD and TMD. Crystallization of GluCl required elimination of residues from both the N- and C termini, as well as replacement of
the cytoplasmic domain (Hibbs andGouaux, 2011). Residues forming the narrowest constriction of the pore in ELIC (L239 and F246) and at analogous positions in
GLIC (I233 and I240/L241) and GluCl (L254 and A261/G262) are shown as yellow spheres.
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homopentameric prokaryotic homologs of the Cys-loop recep-
tors have since been identified (Tasneem et al., 2005). These
bacterial counterparts lack the cysteine residues that frame the
Cys-loop, hence the increasing use of the term pLGIC to
describe the entire superfamily of channels.
The Acetylcholine Binding Proteins
Despite considerable effort (Hertling-Jaweed et al., 1988; Paas
et al., 2003; Padilla-Morales et al., 2011), the Torpedo nAChR
has proven refractory to crystallization, limiting its use for X-ray
crystallographic studies of pLGIC structure. Atomic resolution
insight into the nAChR ABD began to emerge with the discovery
of the so-called acetylcholine binding proteins (AChBP), water-
soluble homologs of the nAChR ABD (Smit et al., 2001). To
date, structures have been solved for four AChBP orthologs in
both the presence and absence of agonists and competitive
antagonists (Billen et al., 2012; Brejc et al., 2001; Celie et al.,
2005; Hansen et al., 2005). The AChBP structures are all homo-
pentamers. Each subunit exhibits a conserved tertiary fold con-
sisting of a short N-terminal a helix followed by a ten-strand b
sandwich core. The b sandwich is formed from an inner b sheet
of six strands (b1, b2, b3, b5, b6, and b8) that is located toward
the central axis of the pentamer and an outer sheet of four
strands (b4, b7, b9, and b10) that is located distally from the
central axis (Figure 2). This same tertiary fold is conserved in
structures of the water-soluble ABDs of the mouse muscle a1
subunit (Dellisanti et al., 2007), the prokaryotic pLGIC, GLIC
(Nury et al., 2010), and an a-7 nAChR ABD/AChBP chimera (Li
et al., 2011). The same tertiary fold is also observed in the full-
length structures of the prokaryotic pLGICs, GLIC and ELIC,
and the C. elegans, GluCl.
The agonist-bound structures of the AChBP confirm that the
agonist-binding sites are formed by loops from both the principle
and complementary subunits (Figure 2A) (Brejc et al., 2001; Sine,1272 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reser2002). Conserved aromatic residues, at positions analogous to
those in loops A, B, and C on the principle face of the nAChR a
subunit, form an ‘‘aromatic box’’ that surrounds the charged
amine of bound agonists. AChBP-specific contributions to
agonist binding are located on the complementary face of the
agonist site and account for variations in agonist affinity between
the different AChBP orthologs and between AChBP and different
nAChRs (Hansen et al., 2004; Rucktooa et al., 2009; Smit et al.,
2001). AChBP has proven to be an excellent structural surrogate
for probing agonist recognition (Cromer et al., 2002; Reeves and
Lummis, 2002; Rucktooa et al., 2009), especially for the homo-
pentameric a7 nAChR with which it shares a similar pharmaco-
logical profile (Brejc et al., 2001; Smit et al., 2001).
Agonist binding to AChBP elicits conformational change, sug-
gesting that AChBP could serve as a surrogate for studying the
structural rearrangements in the binding site that initiate pLGIC
gating (Bourne et al., 2005; Hansen et al., 2002; Hansen et al.,
2005). Support for this was obtained with the creation of a func-
tional chimera between AChBP and the TMD of the 5-HT3 recep-
tor (Bouzat et al., 2004), although function was only obtained
after replacement of the three TMD-facing loops, b1–b2, b6–
b7, and b8–b9, of AChBP with the corresponding loops of the
5-HT3 receptor. Nevertheless, this chimera suggests that the
conformational changes induced in AChBP upon agonist binding
resemble those leading to gating in full-length pLGICs.
The structural changes elicited by agonist binding to the
AChBP orthologs, as well as to the a7/AChBP chimera, suggest
common themes. First, residues in both the agonist-binding
pocket and the two b sheets exhibit conformational flexibility
but lock into a defined conformation in the agonist-bound state.
This is most notable with the agonist-site C-loop, which in the
absence of agonist extends tangentially from the protein
exposing the binding site to solvent (Figure 3A). The precise
position of the C-loop, however, varies both between structures
and within subunits of individual structures (Li et al., 2011). Inved
Figure 2. The Agonist Binding Domain
(A) Residues contributing to the agonist binding site of the Torpedo nAChR were identified by biochemical studies on noncontiguous loops A, B, and C from the
principle (+) (Dennis et al., 1988; Fu and Sine, 1994; Galzi et al., 1990; Kao and Karlin, 1986; Middleton and Cohen, 1991; Silman and Karlin, 1969), and loops D, E,
F from the complimentary () (Corringer et al., 1995; Czajkowski et al., 1993; Fu and Sine, 1994; Martin et al., 1996; O’Leary et al., 1994; Prince and Sine, 1996;
Sine et al., 1995), subunits (top panel). Cartoonmodified from Corringer et al. (2000). A close-up view of the agonist binding site of Lymnaea stagnalis AChBPwith
bound agonist; carbamylcholine (PDB ID code 1UV6) is shown in the lower panel, looking at the binding site from the side (same view as in B). The principle and
complimentary faces are highlighted in yellow and blue, respectively. Interacting residues are highlighted as sticks. The polypeptide backbone is shown as a
transparent cartoon. Carbamylcholine is highlighted as multicolored spheres. Aromatic residues interact with the quaternary amine of acetylcholine/
carbamylcholine via cation-p electron interactions (Dougherty, 1996; Fu and Sine, 1994).
(B) Structure and tertiary fold of the ‘‘Holo’’ form of L. stagnalis AChBP (PDB ID code 1I9B) viewed from both the side and the top (top and bottom panels,
respectively). Subunits are colored to highlight the pentameric quaternary structure. AHEPESmolecule bound to one site is highlighted asmulticolored spheres in
the side view.
(C) The tertiary fold of a single AChBP subunit shown in an orientation similar to that of the yellow subunit in the top panel of (B). The b strands comprising the inner
and outer b sheets are highlighted in blue and red, respectively. The eponymousCys-loop is green, whereas the C-loop is yellow. Both the vicinal disulfide bond in
the C-loop and the disulfide bond closing off the Cys-loop are shown as orange sticks. A topology map of the AChBP protomer is shown in the bottom panel with
the same color scheme, highlighting loops A–F.
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neurotoxin antagonists, which are thought to stabilize the resting
state (Baenziger et al., 1992; Herz et al., 1987; Moore and
McCarthy, 1995). Upon agonist binding, the C-loop moves
toward the channel pore, thus capping the bound agonist, as
suggested by both molecular dynamics (MD) simulations and
fluorescence quenching studies (Gao et al., 2005).
Agonist binding draws together aromatic residues to stabilize
the quaternary ammonium of acetylcholine and recruits addi-
tional residues to mediate signal transduction (Li et al., 2011).
In particular, aromatic residues in loops A (b7 Tyr91) and C (b7
Tyr184) move toward the anchoring loop B Trp residue (b7
Trp145) in the aromatic box. The F-loop in the complementary
subunit moves toward the bound agonist. These local changes
propagate to the rest of the protein primarily by subtle rotationsStructof the outer b sheet, leading to a repacking of the b sandwich
core. The repacking of the b sandwich is highlighted by a rotamer
switch of a conserved aromatic (Phe or Tyr) residue in b10 (b7
Phe196). These rotations cause the outer b sheet to bend toward
the central pore axis, while the position of the inner b sheet re-
mains essentially unchanged.
Although both the detected movements of the C-loop and the
altered packing of the b sandwich core are conserved features in
the gating of the Torpedo nAChR, a complete description of the
conformational pathway leading from the agonist site to the TMD
has, unfortunately, not been obtained. This is partly due to the
fact that structures of AChBP cannot be unequivocally attributed
to the resting and open conformations observed with full-length
pLGICs. For example, some of the Apo AChBP structures exhibit
solute electron density in the aromatic box, leading to theure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1273
Figure 3. Structural Transitions of the
Agonist Binding Domain
(A) Ligand-induced conformational change in
the Aplysia californica AChBP, highlighting
movement of the C-loop (colored). The structures
on the top left (PDB ID code 2BYP) and top right
(PDB ID code 2BYQ) are with the bound peptidic
a-conotoxin antagonist, IMI, and the bound
agonist, epibatidine, respectively. In both struc-
tures, loops and a helices at the top of each
subunit have been removed to provide an unob-
structed view of the C-loop. Below, the agonist
sites of individual protomers in the presence of
IMI, the absence of ligand (PDB ID code 2BYN),
and in the presence of epibatidine are super-
imposed with their C-loops colored blue, trans-
parent gray, and red, respectively. Epibatidine is
highlighted as multicolored spheres. The arrow
shows the movement of the C-loop upon agonist
binding.
(B) Superposition of the Torpedo a- and d-subunit
(PDB ID code 2BG9). Vibrant colors were chosen
for the a subunit, whereas the corresponding pale
colors were used for the d-subunit. Arrows show
the movements of the inner and outer b sheets required to superimpose the non-a-subunit (in this case d) onto the ‘‘strained’’/unliganded a subunit. The top of
the transmembrane a helices and the M2–M3 linker (red) are shown for the a subunit, with a conserved Pro residue (aP286) highlighted as red spheres.
Structure
Reviewsuggestion that they resemble more closely a desensitized state
(Brejc et al., 2001; Celie et al., 2005; Grutter and Changeux,
2001). Even Apo AChBP structures that lack solute electron den-
sity in the agonist site undergo a further opening of the C-loop
upon binding toxins, which are thought to stabilize the resting
nAChR (Figure 3B). In addition, the formation of a resting state-
like AChBP/5-HT3 chimera was only achieved when AChBP
was appropriately complexed with a complementary TMD (Bou-
zat et al., 2004). As the presence of a TMD appears to influence
the conformations of the ABD, soluble AChBPs cannot offer
definitive insight into the structural changes leading to pLGIC
gating.
The Torpedo nAChR
Nigel Unwin and colleagues have used cryo-electron micro-
scopy (cryo-EM) since 1984 to image membrane-imbedded
nAChR-enriched tubes formed from native Torpedo elelctropla-
que membranes. Extensive studies culminated in a 4.0 A˚ resolu-
tion structure of the closed/resting nAChR pore in 2003
(Miyazawa et al., 2003), which was subsequently refined by
incorporating the AChBP crystal structure in 2005 (Unwin,
2005). The 4.0 A˚ model provided the first direct insight into the
structure of the TMD, confirming the existence of four mem-
brane-spanning a helices in each subunit, as initially predicted
by hydropathy plots (Schofield et al., 1987). The a-helical nature
of the TMD was subsequently reinforced by nuclear magnetic
resonance (NMR) structures of the TMD of the neuronal a4b2
nAChR (Bondarenko et al., 2012, 2013) and by crystal structures
of full-length prokaryotic pLGICs (see below). Unwin’s refined
model highlights the structurally distinct ABD, TMD, and cyto-
plasmic domains, although much of the latter structure is still
unresolved.
Unlike the AChBP, the nAChR is a heteropentamer formed
from four different but homologous subunits. The conformations
of the b-, g-, and d-subunit ABDs are similar to the agonist-bound
AChBP protomer, whereas the ABDs of the two a subunits adopt
a distinct ‘‘strained’’ conformation. In the a subunits, the inner b1274 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights resersheets are rotated counterclockwise relative to the other sub-
units (Figure 3B) (Unwin, 2005; Unwin et al., 2002). In addition,
the C-loops in the a subunits are extended, similar to that seen
in unliganded AChBP structures (Celie et al., 2004; Hansen
et al., 2005; Unwin et al., 2002). These differences led to the sug-
gestion that agonist binding leads to closure of the C-loop and
relaxation of the inner b sheets to a more non-a/AChBP-like
conformation. Because the inner sheet of the ABD is directly
above the channel lining M2 a helix, it was originally suggested
that a change in structure of this b sheet couples directly to a
change in structure of the pore. Coupling was proposed to be
mediated primarily by interactions between aVal46 of the b1–
b2 loop and aPro272 of the M2–M3 linker. More recent struc-
tures, however, suggest that asymmetric motions of the different
subunits ultimately lead to relatively large changes in conforma-
tion of the b subunit, which plays the key role in transmitting
changes from the agonist-binding site to the channel gate
(Unwin and Fujiyoshi, 2012).
Several loops at the interface between the ABD and the TMD
are key to the allosteric transition that links the ABD to the chan-
nel gate (Andersen et al., 2011; Bouzat et al., 2004, 2008; Chak-
rapani et al., 2004; Grutter et al., 2005; Jha et al., 2007; Kash
et al., 2003; Lee et al., 2009; Lee and Sine, 2005; Reeves et al.,
2005; Shen et al., 2003; Xiu et al., 2005), as reviewed elsewhere
(Bouzat, 2012). The ABD is linked covalently to the TMDby a loop
between b10 and M1. The b1–b2, b6–b7 (Cys-loop), and the b8–
b9 loops extend down toward the TMD, with the former two
directly contacting a short linker between the M2 and M3 trans-
membrane a helices, known as the M2–M3 linker. The M2–M3
linker is a well-established gating control element (Campos-
Caro et al., 1996; Grosman et al., 2000; Jha et al., 2007; Lee
and Sine, 2005; Lynch et al., 1997; Rovira et al., 1998, 1999).
Mutations within this linker affect nAChR apparent gating
kinetics without altering the nAChR’s affinity for agonist (Gros-
man et al., 2000). Unnatural amino acid substitutions suggest
that channel opening in the homologous 5-HT3 receptor is
directly related to the cis-trans conformational preference of anved
Figure 4. The Transmembrane Pore
(A) Right: side view surface diagram of the Torpedo nAChR pore (PDB ID code
2BG9) with the g-subunit removed to provide an unobstructed view of the ion
channel lumen. The M2 helices lining the pore are colored blue, whereas the
rings of negative/polar residues that play a role in ion selectivity are red. The
narrowest region of the pore corresponding to the hydrophobic gate is shown
in yellow. Left: a ribbon representation of the aM2 transmembrane a helix
showing the relative position of the highlighted residues lining the pore in the
accompanying surface diagram.
(B) Top row: view looking toward themembrane surface of the transmembrane
pore formed by the M2 a helices of each subunit in the Torpedo nAChR (left;
PDB ID code 2BG9), ELIC (center; PDB ID code 2VLO), andGLIC (right; PDB ID
code 3EAM). The residues highlighted as yellow spheres in the nAChR and
ELIC form the narrowest constriction of each pore. In GLIC, the highlighted
yellow residues are at positions analogous to those in ELIC. Bottom row: view
of both the pore and the interface between the agonist binding and trans-
membrane domains from within the plane of the membrane showing potential
movements of the pore-lining a helices upon channel gating and/or uncoupling
(see text). For clarity, only two subunits are shown for each pLGIC (for the
nAChR two a subunits). For each subunit, the transmembrane a helices M2
and M3 (blue), the M2–M3 linker (red), and both the b1–b2 (light blue) and b6–
b7 (dark green) loops are shown. A conserved proline residue is highlighted as
red spheres in analogous positions of the M2–M3 linker in the nAChR (aP286),
ELIC (P253), and GLIC (P247).
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Unfortunately, the specific changes in conformation at the inter-
face between the ABD and TMD that lead to movement of the
pore-lining TMD a helices remain poorly defined at the current
resolution of the open structure (6 A˚).
The TMD pore is lined with theM2 a helices from each subunit.
These pore lining a helices contain three rings of charged/polar
residues that confer ion selectivity (aE241, aE262, aS266, and
the corresponding residues from other subunits) (Figure 4A).
In the nAChR’s closed conformation, the a helices bend toward
the center of the pore leading to a narrow region formed by threeStructrings of hydrophobic residues (aL251, aV255, aV259, and the
corresponding residues from other subunits). At the level of
aL251 and aV255, the pore constriction is both too narrow
(6.0 A˚ diameter) and too hydrophobic to allow the passage of
a hydrated sodium or potassium ion (8.0 A˚). By making it ener-
getically unfavorable for a permeating ion to shed its solvating
waters, these residues are thought to constitute a ‘‘hydrophobic
gate’’ (Beckstein and Sansom, 2006; Ivanov et al., 2007; Miya-
zawa et al., 2003). This constricted structure is stabilized by
hydrophobic interactions between residues on adjacent M2 a
helices, and structural rearrangements underlying gating are
thought to break these interactions leading to a widening of
the pore. Also, the narrowest constriction of the pore in the
open state is closer to the cytoplasmic leaflet of the bilayer
(Unwin and Fujiyoshi, 2012), consistent with a recent analysis
of ion permeation through the prokaryotic homolog, GLIC
(Sauguet et al., 2013b).
Cryo-EM images recorded from nAChRs trapped in the open
state at 9.0 A˚ resolution originally suggested that pore opening
results from a clockwise rotation of the five pore lining M2 heli-
ces, causing them to collapse against the outer ring of TMD
helices (Law et al., 2005; Unwin, 1995), although functional
studies suggest rigid body tilting (Cymes and Grosman, 2008;
Cymes et al., 2005; Paas et al., 2005). Both models are consis-
tent with the observation that the relative stability of the open
state is dependent upon the volume and stereochemistry of res-
idues within M3 (Wang et al., 1999). More recent and higher res-
olution images suggest that although each of the pore liningM2 a
helices move most in the extracellular leaflet, individual M2s
exhibit distinct and complex movements (Unwin and Fujiyoshi,
2012). Some helices tilt outward, whereas others straighten
from a ‘‘bowed’’ conformation. Although these rearrangements
only increase the limiting diameter of the pore by about 1 A˚,
they also diminish pore hydrophobicity by exposing previously
buried polar residues. These subtle, yet complex, movements
are consistent with those suggested by both MD simulations
and functional measurements examining gating (Beckstein and
Sansom, 2004; Cymes and Grosman, 2008; Cymes et al.,
2005; Song and Corry, 2009; Wang et al., 2008, 2009).
Note that as the resolution of available structures has
increased, so has the depth of understanding. In fact, structural
models of gating have evolved, with some original featuresmain-
tained and others discarded. The evolution in our understanding
of nAChR gating with increasing resolution of the solved struc-
tures serves as a reminder that further improvements in resolu-
tion will likely lead to further insight.
pLGIC Crystal Structures and Comparison with the
Torpedo nAChR
A major breakthrough in the structural characterization of
pLGICs arrived with the identification of several prokaryotic
pLGICs (Bocquet et al., 2007; Tasneem et al., 2005). Two of
these, GLIC and ELIC, are cation-selective channels gated by
protons and primary amines (including GABA), respectively
(Bocquet et al., 2007; Zimmermann and Dutzler, 2011). Both
homopentamers are expressed in Escherichia coli at levels suf-
ficient for biochemical and structural studies. Both also exhibit
drug sensitivities similar to other pLGICs (Thompson et al.,
2012; Weng et al., 2010). GLIC and ELIC thus serve as excellenture 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1275
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Reviewmodels for probing both the mechanisms of channel activation
and pLGIC-drug interactions.
The crystal structure of ELIC solved in 2008 (Hilf and Dutzler,
2008) was quickly followed by crystal structures of GLIC (Boc-
quet et al., 2009; Hilf and Dutzler, 2009) and theC. elegans, GluCl
(Hibbs and Gouaux, 2011). These structures revealed conserved
tertiary and quaternary folds, as well as conserved motifs, such
as the rings of charged and hydrophobic residues that line the
ion channel pore conferring ion selectivity and forming the chan-
nel gate (Figure 4A). The prokaryotic pLGICs, however, lack both
the cysteine residues that bracket the Cys-loop and the cyto-
plasmic domain located between M3 and M4. The pore lining
M2 a helices in the GLIC, ELIC, and GluCl structures also
display a whole helix turn shift in register. Structures of ELIC,
GLIC, and GluCl have been solved in the presence of a variety
of ligands (Corringer et al., 2012; Gonzalez-Gutierrez et al.,
2012; Hilf et al., 2010; Nury et al., 2011; Pan et al., 2012a,
2012b; Sauguet et al., 2013a; Zimmermann and Dutzler, 2011;
Zimmermann et al., 2012).
The TMD Pore
The first crystal structure of the pLGIC, ELIC, was solved in the
absence of agonist and attributed to the closed conformation
(Hilf and Dutzler, 2008). In agreement with this interpretation,
the TMD pore is occluded with hydrophobic side chains steri-
cally blocking the pore (Figure 4B). Crystal structures of GLIC
and GluCl were subsequently solved in the presence of acti-
vating ligands and thus proposed to be stabilized in an open
state (Bocquet et al., 2009; Hibbs and Gouaux, 2011; Hilf and
Dutzler, 2009). Consistent with this hypothesis, the C termini of
the pore-lining a helices in the GLIC and GluCl structures tilt
away from the central channel axis (relative to the ELIC struc-
ture), leading to an increase in pore diameter suggestive of an
open and conductive conformation (Figure 4B). In further sup-
port of an open conformation, disulfide-linked cystine mutants
of GLIC designed to lock the channel in a closed ELIC-like
conformation reduce the pore diameter, demonstrating that
closed conformations of GLIC with narrower pore diameters
exist. This latter closed structure may represent an intermediate
in the pathway, leading to channel gating (Prevost et al., 2012).
GluCl was cocrystallized with the open channel blocker, picro-
toxin. Electron density for the blocker was observed in the chan-
nel pore, suggesting that the GluCl channel is open (Hibbs and
Gouaux, 2011). It should be mentioned that picrotoxin can be
trapped in the closed pore of the homologous GABAA receptor
(Bali and Akabas, 2007; Xu et al., 1995). Finally, a structure
solved of GLIC at 2.4 A˚ reveals the detailed hydration of a sodium
ion within the pore of the open state. Computer simulations
describe the changes in hydration that occur as a sodium ion
transitions through the channel pore of this structure (Sauguet
et al., 2013b). Collectively, these data are consistent with the
assignment of the ELIC and the GLIC/GluCl structures to closed
and open pore conformations, respectively.
The interpretations of the ELIC and the GLIC/GluCl structures
in terms of closed and open conformations, however, are not
easily reconcilable with the closed and open structures of the
Torpedo nAChR (Figure 4B). The nAChR structure solved in the
absence of agonist is presumably in the closed conformation
(Unwin, 2005). In contrast to ELIC, the closed nAChR structure
exhibits a channel pore that narrows to only 6 A˚ in diameter.1276 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserThe narrow constriction forms a hydrophobic, rather than a ste-
ric, barrier to ion flow (Beckstein and Sansom, 2006). In addition,
the orientations of the pore lining a helices in the nAChR struc-
ture are similar to the orientations of the pore-lining a helices in
the structures of both GLIC and GluCl. In fact, the pore diameter
of the ‘‘closed’’ nAChR resembles more closely that of the open
GLIC (and GluCl) than that of the closed ELIC (Figure 4B).
Furthermore, cryo-EM images of the nAChR in both the closed
and open conformations suggest that the changes in orientation
of the TMD a helices upon gating are subtle and lead to only
minor changes in pore diameter—not the relatively large
changes observed between the GLIC and ELIC structures (Boc-
quet et al., 2009; Hilf and Dutzler, 2008, 2009).
One possible interpretation is that the apparent conforma-
tional ambiguities between the nAChR and ELIC/GLIC/GluCl
structures reflect intrinsic structural differences between the
pores and/or differences in the gating mechanisms of the
different orthologs. In an attempt to eliminate this ambiguity,
crystal structures of ELIC have been solved in both the presence
and absence of an activating ligand (Gonzalez-Gutierrez et al.,
2012; Zimmermann and Dutzler, 2011). Although additional elec-
tron density was observed in the agonist binding pockets of
ELIC, suggesting agonist binding, no structural rearrangements
were detected in the TMD pore. In fact, no movement of the
pore-lining M2 a helices was detected with mutants that prolong
channel opening and exhibit no propensity to desensitize
(Gonzalez-Gutierrez et al., 2012). It has been suggested that
the ELIC crystal structures reflect a state distinct from the ex-
pected closed, open, or desensitized states (Gonzalez-Gutierrez
and Grosman, 2010).
The Coupling Interface between the ABD and TMD
Intimate interactions between structures at the interface
between the ABD and TMD mediate coupling of agonist binding
to channel gating. Given the ambiguity in the pore diameters of
ELIC/GLIC/GluCl versus the nAChR, it is intriguing to compare
the conformations of the loops at this interface. Subtle, but sig-
nificant, differences are observed between the closed ELIC
and open GLIC/GluCl structures (Bocquet et al., 2009; Hibbs
andGouaux, 2011; Hilf andDutzler, 2009). Relative to ELIC, there
is a downward motion of the b1–b2 loop in GLIC/GluCl and a
displacement of both the b6–b7 loop and the M2–M3 linker
away from the central pore axis so that the b1–b2 loop is now
located on the proximal side (relative to the channel pore) of a
conserved proline (Torpedo aP272) in the M2–M3 linker
(Figure 4C). These movements are accompanied by an outward
tilt of the C termini of the five M2 a helices, leading to an expan-
sion of the pore diameter. The largest changes in the diameter of
the pore occur in the extramembranous leaflet of the bilayer,
consistent with the most recent structural data for the open state
of the nAChR (Unwin and Fujiyoshi, 2012).
Surprisingly, the structural differences at this interface
between the closed and open conformations of ELIC and GLIC
are subtle in comparison to those between ELIC/GLIC and the
nAChR (Figure 5A). In the nAChR, the extended side chains of
the b1–b2 and b6–b7 loops engage theM2–M3 linker in a fashion
reminiscent of vice grips attached to a metal pipe. Specifically,
the side chains aE45 and aV46 in the b1–b2 loop form an inverted
‘‘V’’ that interacts with both faces of aP272 in the M2–M3 linker.
The b6–b7 loop forms an inverted ‘‘Y’’ with side chains aV132ved
Figure 5. The Interface between the Agonist
Binding and Transmembrane Domains
(A–C) A single subunit of (A) the nAChR (a subunit)
(PDB ID code 2BG9), (B) ELIC (PDB ID code 2VLO),
and (C) GLIC (PDB ID code 3EAM) viewed from the
membrane plane, highlighting the coupling inter-
face (dashed box). In this orientation, the ion
channel pore is located to the right of each subunit.
The transmembrane a helices, the b1–b2 and b6–
b7 loops, and the M2–M3 linker are colored as in
Figure 4B. Post-M4 is colored orange. Residues
potentially involved in post-M4/b6–b7 loop in-
teractions are highlighted as sticks. Close-up
views showing b1–b2/M2–M3 and b6–b7/M2–M3
interactions are shown on the left and right,
respectively. The three views on the right are each
from a slightly different angle that highlights the
interactions between the b6–b7 loop and the M2–
M3 linker in each protomer.
(B) The terminal 5 residues of M4 are absent in the
structure of ELIC.
(C) The terminal 2 residues of M4 are absent in
the structure of GLIC. A lipid that bridges post-M4
to the b6–b7 loop in GLIC is highlighted as tan
spheres.
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the M2–M3 linker. In contrast, substantially less contact
between the loops of the ABD and the M2–M3 linker of the
TMD is observed in the ELIC, GLIC, and GluCl structures (Fig-
ures 5B and 5C). In the latter, the b1–b2 and b6–b7 loops no
longer surround the M2–M3 linker, which itself tilts down
toward the membrane surface so that it approaches the b8–b9
loop on the complementary face of the adjacent subunit. The
side chains of the b1–b2 loop extend away from the M2–M3
linker flattening the inverted ‘‘V’’ so that it interacts with only
one surface of the conserved proline residue. In addition, the
b6–b7 loop forms an extended rod-like structure that interacts
with a single side of the M2–M3 linker. In the nAChR the b1–
b2 loop forms numerous atom-atom contacts with the M2–M3
linker proline that are %3.0 A˚ apart, whereas in ELIC, GLIC,
and GluCl, the analogous contacts are typically R4.0 A˚ apart.
Thesecomparisons showthat theconformationsof the loopsat
the interface between the agonist-binding and TMDs in theStructure 21, August 6, 2013 ªnAChR bear little resemblance to the con-
formations of the same loops in ELIC,
GLIC, and GluCl, raising further questions
regarding the conformational interpreta-
tion of the various structures. Signifi-
cantly,whereas theELIC,GLIC, andGluCl
structures suggest that gating results
from increased interactions between the
ABD and TMD upon agonist binding, the
nAChR structure suggests that tight inter-
actions between the two domains already
exist in the agonist-free state.
Factors Contributing to the
Conformational Ambiguity
Based on both pore diameter and the ge-
ometry of the M2 a helices, the nAChR in
the absence of agonist appears to be in asimilar open structure to that of GLIC and GluCl, whereas the
ELIC structure appears to be closed. The assignment of the
nAChR to an open conformation, however, is not easily reconcil-
able with the absence of an activating ligand. The relatively large
differences in diameter of the channel pores between the closed
ELIC and open GLIC structures are also not consistent with the
subtle changes in nAChR pore diameter that are observed by
cryo-EM upon activation and that are further supported by func-
tional studies andMD simulations (Beckstein and Sansom, 2004;
Cymes and Grosman, 2008; Cymes et al., 2005; Song and Corry,
2009; Unwin and Fujiyoshi, 2012; Wang et al., 2008, 2009). On
the other hand, based on the structures of the coupling interface
between the ABD and TMD, the nAChR adopts a conformation
distinct from those of both the closed ELIC and the open
GLIC/GluCl. Given that the interpretation of these structures
impacts on our understanding of the mechanisms of channel
activation, the question that arises is how to reconcile these
structural differences.2013 Elsevier Ltd All rights reserved 1277
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tion of the various structures. The closed and open nAChR struc-
tures were solved at 4.0 and 6 A˚ resolution, respectively,
whereas the structures of GLIC, ELIC, and GluCl were all
determined at higher resolution (2.4–3.3 A˚). Although the lower
precision of the nAChR structures undoubtedly leads to some
ambiguity, it seems unlikely that the lower precision by itself
accounts for the relatively large differences in pore diameter
between the closed nAChR and ELIC structures, as well as the
substantial differences observed between the cryo-EM and
crystal structures at the interface between the ABD and TMD.
In addition, the lower precision of the nAChR structures does
not explain the lack of structural change in the pore upon
agonist-binding to ELIC (Gonzalez-Gutierrez et al., 2012; Zim-
mermann and Dutzler, 2011).
Another possibility is that the structural discrepancies
between the pLGICs reflect intrinsic structural differences and/
or distinct activation mechanisms. The open GluCl structures
were solved in the presence of both agonist and the allosteric
ligand, ivermectin, which contributes to channel opening by
wedging between the M1 and M3 a helices of the TMD (Hibbs
and Gouaux, 2011). The activating ligand of GLIC is a proton,
which does not bind to the typical aromatic box found in the
binding sites of other pLGICs. A protonation site in the TMD of
GLIC has also been implicated in gating (Wang et al., 2012),
although a chimera formed between the ABD of GLIC and the
TMD of the glycine receptor still responds to protons (Duret
et al., 2011). The activationmechanisms revealed by these struc-
tures may thus differ from the classical activation of the nAChR
resulting from agonist binding to its canonical site. The similarity
of the open structures of GLIC and GluCl, despite proton and
ivermectin binding to distinct sites, however, suggests a com-
mon activation mechanism for both GLIC and GluCl. Further-
more, the possibility of distinct activation mechanisms, and
thus potentially distinct closed states, does not explain the
absence of conformational change in the pore structure of
agonist-bound ELIC.
In this light, it may be significant that the Torpedo nAChR is a
heteropentamer, whereas ELIC, GLIC, and GluCl are all homo-
pentamers. The proposed gating mechanism of the Torpedo
nAChR suggests differential roles for the agonist-binding a
versus the non-a subunits. In addition, the Torpedo nAChR re-
quires only two bound agonist molecules for maximal stabiliza-
tion of the open state, whereas an a7/5-HT3 homopentameric
chimera requires occupation of three agonist sites for maximal
opening (Rayes et al., 2009). There may be subtle differences
in the activation mechanisms of hetero- versus homopentameric
channels. The fact that some subunits form both homo- and het-
eropentamers (Lummis, 2012), however, argues against distinct
activation mechanisms in homomeric ELIC/GLIC/GluCl versus
the heteromeric nAChR.
The transient nature of the open state may also complicate
interpretation of the pLGIC structures. The prolonged stabilities
of the open conformations of crystallized GLIC, GluCl, and
ELIC in the presence of activating ligands have not been un-
equivocally demonstrated. ELIC undergoes desensitization after
exposure to activating ligands, such as cystamine, although
nondesensitizing mutants have been identified (Gonzalez-
Gutierrez et al., 2012). Although it was originally suggested that1278 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserGLIC did not desensitize in response to proton binding (Bocquet
et al., 2007), this interpretation has been challenged (Gonzalez-
Gutierrez and Grosman, 2010; Parikh et al., 2011; Velisetty
et al., 2012). Membrane-reconstituted GLIC rapidly desensitizes,
albeit at activating pH values that are below those used in crys-
tallographic studies (Velisetty and Chakrapani, 2012). These
recent findings raise the possibility that the agonist-bound struc-
tures of both GLIC and ELIC are influenced by desensitization
(Parikh et al., 2011; Velisetty and Chakrapani, 2012; Velisetty
et al., 2012). The possibility that GLIC and ELIC adopt a desen-
sitized conformation, however, does not explain the substantial
structural differences between GLIC and ELIC, particularly in
the diameters of their TMD pores.
Lipid and Detergent Sensitivity of pLGICs
Another potential complication arises from the fact that the
nAChR structure was solved by cryo-EM in its native Torpedo
membrane, whereas the structures of ELIC, GLIC, and GluCl
were each solved by X-ray diffraction in the detergent-solubilized
state. Crystal packing forces may influence the conformations
adopted by the crystallized pLGICs (Kollman et al., 2009). Deter-
gent molecules interact closely with the pore-lining M2 a helices
in structures ofGLIC (Bocquet et al., 2009; Sauguet et al., 2013b).
Given that detergent-solubilization can influence the conforma-
tion of any membrane protein extracted from its lipid environ-
ment, it is prudent to question whether the crystallized pLGIC
structures are influenced by detergent solubilization andwhether
this might be the source of conformational ambiguity. In this
context, it should be noted that there are currently no published
data directly characterizing the functional properties of ELIC,
GLIC, or GluCl in the detergent-solubilized state. In fact, it re-
mains tobedeterminedwhether agonist-induced conformational
transitions even occur after detergent solubilization.
Although the conformational sensitivity of ELIC, GLIC, and
GluCl to lipids and detergent has not been extensively studied
(Labriola et al., 2013; Velisetty and Chakrapani, 2012), lipids
are observed bound to the surface of crystallized GLIC
(Figure 5C) and may thus play a role in GLIC function (Bocquet
et al., 2009). Recent studies highlight the sensitivity of the
GLIC TMD to allosteric modulators (Bro¨mstrup et al., 2013; this
issue of Structure). On the other hand, complex relations have
been documented between lipids and the conformational land-
scape of the Torpedo nAChR (Asmar-Rovira et al., 2008; Baen-
ziger and daCosta, 2013; Barrantes, 2002; Criado et al., 1984;
daCosta et al., 2009; Fong and McNamee, 1986; Hamouda
et al., 2006; Rankin et al., 1997). Some reconstitutedmembranes
stabilize the nAChR in an activatable conformation, whereas
others favor either a desensitized or a distinct conformation
that binds agonist and other ligands with low resting-state like
affinities but does not undergo agonist-induced conformational
change (daCosta and Baenziger, 2009). In the latter, binding
of agonist is uncoupled from both channel gating and desensiti-
zation, as is apparently the case with the crystallized ELIC
(Gonzalez-Gutierrez et al., 2012). A similar uncoupled conforma-
tion has been observed upon detergent solubilization of the
nAChR (Heidmann et al., 1980), raising the concern that deter-
gent solubilization could have similar effects on other pLGICs.
One defining property of the uncoupled nAChR is that re-
gions of the polypeptide backbone that are buried from solventved
Figure 6. The Uncoupled State
(A) The nAChR from native Torpedo membranes undergoes agonist-induced conformational transitions from resting (R) to open (O) and then desensitized (D)
conformations (scheme 2). The nAChR in reconstitutedmembranes also adopts an uncoupled conformation that binds agonist but typically does not transition to
the open or desensitized states (scheme 1).
(B) Schematic diagram showing the current model of lipid-dependent uncoupling, illustrated using a single nAChR subunit. The lipid exposedM4 likely plays a key
role in sensing the lipid bilayer. In unfavorable membrane environments, the conformation of M4 may change, thus weakening interactions between the b1–b2
(light blue)/b6–b7 (green) loops of the ABD and the M2–M3 linker (red) of the TMD (for details, see daCosta and Baenziger, 2009).
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exposed to solvent in the uncoupled state (daCosta and
Baenziger, 2009; Me´thot et al., 1995). Given the importance
of the coupling interface in nAChR function, it has been sug-
gested that lipid-dependent uncoupling results from weakened
interactions, and increased physical separation, between the
ABD and TMD (daCosta, 2006; daCosta and Baenziger,
2009), similar to the mechanism of coupling/uncoupling asso-
ciated with the PIP2-activated potassium channel (Hansen
et al., 2011). Lipids and detergents could influence interactions
between the ABD and TMD via the C terminus of the lipid-
exposed M4 a helix, which in the nAChR structure interacts
directly with the b6–b7 loop (Figure 4B). Although the
functional significance of this putative interaction has yet to
be demonstrated, the importance of the C terminus of M4 in
nAChR function is well documented (Hosie et al., 2006; Jin
and Steinbach, 2011; Paradiso et al., 2001; Pons et al.,
2004; Tobimatsu et al., 1987).
As noted, the coupling interface of the Torpedo nAChR ex-
hibits tight interactions between the ABD and TMD, whereas in
ELIC, GLIC, and GluCl these contacts are weaker. Given that
the structures of ELIC, GLIC, and GluCl were solved in the deter-
gent-solubilized state, it is conceivable that contact between
the ABD and TMD is influenced by detergent-solubilization.
One possible interpretation is that the weakened interactions
observed between the two domains could be similar to those
thought to underlie the increased solvent accessibility detected
with the uncoupled Torpedo nAChR in unfavorable lipid environ-
ments. In this vein, it is interesting that the M4 a helix in the ELIC
structures is partially unwound and tilted away from the remain-
ing TMD with several C-terminal M4 residues not modeled
(Figure 5B). Contrasted with the nAChR structure (and that of
GLIC and GluCl), the ELIC structure does not exhibit contacts
between the C terminus of M4 and the b6–b7 loop, precisely
the type of structural rearrangements thought to underlie lipid-
dependent uncoupling (Figure 6B).StructA lipid-dependent uncoupled conformation of ELIC would
explain both the lack of agonist-induced structural change in
the crystal structures of ELIC (Gonzalez-Gutierrez et al., 2012)
and would largely reconcile the conformational ambiguities
between available pLGIC structures. Rather than representing
the canonical closed state, the conformation of the pore in the
ELIC structure would instead reflect the distinct uncoupled state.
If this interpretation is correct, then the GLIC/GluCl and the 4.0 A˚
nAChR structures may still reflect the open state and closed
states, respectively. In this scenario, these structures would sug-
gest that only subtle changes in pore diameter occur upon chan-
nel gating, consistent with the cryo-EM studies of nAChR gating,
broader functional studies, and MD simulations (Beckstein and
Sansom, 2004; Cymes and Grosman, 2008; Cymes et al.,
2005; Song and Corry, 2009; Unwin and Fujiyoshi, 2012; Wang
et al., 2008, 2009). Strictly speaking, a definitive interpretation
of each crystal structure in terms of a specific conformation still
requires experimental characterization of the conformation
adopted in the crystalline state.
Summary and Future Directions
Our current understanding of pLGIC structure stems from
several major breakthroughs over the past 50 years, including
the identification of the Torpedo nAChR as an abundant model
for biochemical studies, the discovery and structural character-
ization of molluscan AChBPs, continued technical improve-
ments in the EM imaging of Torpedo nAChRs, the discovery
and structural characterization of prokaryotic pLGICs, and the
first X-ray structure of a eukaryotic pLGIC, GluCl. Each of these
advancements generated new lines of investigation that collec-
tively led to detailed new insight into both structure and function,
but each line of investigation has its challenges and limitations.
The Torpedo nAChR is abundant and amenable to biochemical
studies but has proven refractory to crystallization. The AChBP
and other water-soluble ABDs are amenable to crystallization
without the complicating issues of detergent-solubilization, buture 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1279
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Cryo-EM studies of the Torpedo nAChR have yielded critical
insight into the structures of both the closed and open states
and are unaffected by potential effects of detergent solubiliza-
tion, but the interpretation of these structures is limited by cur-
rent resolution. Prokaryotic pLGICs are relatively easy to express
and crystallize, but little is known about their functional proper-
ties in the detergent-solubilized state.
Thus, despite exciting progress, a number of open questions
remain surrounding the interpretation of different conformations
captured for different channels by different techniques. The
conformational ambiguities between the Torpedo nAChR struc-
ture and those of ELIC, GLIC, and GluCl could reflect many fac-
tors, including the effects of crystal packing forces, differences in
the resolution of the determined structures, intrinsic differences
in the activation mechanisms of each pLGIC, and the possible
transient nature of the open conformation in the presence of acti-
vating ligands. We contend that detergent-solubilization has the
potential to exert significant influence on the conformations of
the crystallized pLGICs and that some of the crystallized struc-
tures exhibit features consistent with the uncoupled nAChR
conformation observed in unfavorable membranes. Further
work is required to develop probes that can be used to examine
the functional properties of pLGICs in the detergent solubilized
state and thus to unequivocally assess conformations adopted
during crystallization. An understanding of how lipids and deter-
gents influence pLGIC structure may also assist in defining
conditions for crystallization in unambiguous conformations.
Ultimately, definitive conformational insight is essential for a
structural understanding of pLGIC function. Conformational
insight is also essential for understanding the nature of drug
action at these important therapeutic targets.ACKNOWLEDGMENTS
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